GIST may arise anywhere in the GI tract and also in extragastrointestinal locations (extragastrointestinal stromal tumor ... location of primary disease was stomach (59.0%), followed by small ...

Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing ...

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according ...

For the first time, scientists have systematically analyzed somatic mutations in stomach lining tissue to unpick mutational ...

Hoth Therapeutics Inc. has released preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST).

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

The American College of Gastroenterology has published its first clinical guideline on the diagnosis and management of ...

This weekend church members of St. Paul Lutheran Church in Wisner are helping put on a benefit to help Pastor Jared Hartman ...

(RTTNews) - Hoth Therapeutics, Inc. (HOTH) Tuesday announced positive preclinical results for HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST). GIST is a rare but ...

Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours: New York Wednesday, March 19, 2025, 18:00 Hrs [IST] Hoth ...

Total 497 GIST patients were involved in present ... Univariate analysis revealed that male gender, non-gastric origin, larger tumor size, higher mitotic rate, higher risk grade, CD34 negative ...